Where CVS Health Stands With Analysts
Portfolio Pulse from Benzinga Insights
In the past three months, 15 analysts have rated CVS Health, with a mix of bullish and indifferent sentiments. The average 12-month price target has increased by 6.25% to $68.0. Analysts have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. CVS Health's financials show positive revenue growth, strong net margin, and efficient asset management.
October 23, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CVS Health has received mixed analyst ratings over the past three months, with a notable increase in the average 12-month price target to $68.0. Analysts have adjusted their ratings and price targets, indicating a positive shift in sentiment. CVS Health's financials show strong revenue growth and profitability.
The increase in the average price target and positive financial indicators suggest a favorable outlook for CVS Health. Analysts' adjustments in ratings and price targets reflect a positive shift in sentiment, likely boosting investor confidence and short-term stock performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100